An Act amending the act of September 27, 1961 (P.L.1700, No.699), known as the Pharmacy Act, further providing for definitions, for licensing of pharmacists and for unlawful acts; and providing for price disclosure.

Added a new provision allowing the Board to issue provisional licenses to out-of-state pharmacists for 180 days without requiring them to demonstrate competency or verify that their home state's requirements match Pennsylvania's.

Modified the definition of a 'dose package' to include naloxone or other comparable treatment regimens determined by the Secretary of Health.

Changed the language regarding EMS providers distributing dose packages to emphasize that the action is voluntary and explicitly state that providers incur no liability for not stocking or distributing them.

Updated the effective date of the bill from 'Third Consideration' to 'Second Consideration' and changed the title to reflect the addition of pharmacist licensing provisions.

Added a new Section 9.6 requiring pharmacies to disclose brand-name and generic drug prices, consumer cost-sharing amounts, and information on applying for subsidized health coverage upon consumer request.

Established penalties for non-compliance with the new price disclosure requirements, including fines of up to $500 for pharmacies, with an exception for failures due to technological issues.

Refined the definition of 'dose package' to explicitly state it is intended for the reversal of a single opioid-related overdose event.

Changed the effective dates for different parts of the bill; the new price disclosure section takes effect immediately, while other amendments take effect in 60 days or one year.